Latest News and Press Releases

CHENGDU, China and ROCKAWAY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Kanghong Pharmaceutical and Vanotech Ltd. today announced the successful completion of a Phase 2b clinical trial evaluating KH607...

Phase 2b results in TRD published in JAMA PsychiatryGH001-HV-106 study enrolment completed; doses selected for the global Phase 3 pivotal program of GH001 in TRDGH001-HV-109 US IND-opening study...

DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- Guidelight Health today announced the launch of Prism, a specially developed LGBTQIA+ affirming Intensive Outpatient Program (IOP) for adults, expanding...

InStride reports 97% patient improvement in 2026, doubling enrollment and expanding across 5 East Coast markets while maintaining strong clinical results.

neurocare group AG receives SFDA MDMA approval for TMS devices in Saudi Arabia, enabling access to non‑invasive, evidence‑based mental health treatment.

neurocare group AG receives SFDA MDMA approval for TMS devices in Saudi Arabia, enabling access to non‑invasive, evidence‑based mental health treatment.

Alexandria, VA, May 01, 2026 (GLOBE NEWSWIRE) -- In 2025, 97,000 people under the age of 18 in the United States took a depression screening on Mental Health America’s website, and 51% reported...

The latest GeneSight® Mental Health Monitor from Myriad Genetics reveals that Americans feel mental health treatment isn’t designed with them in mind.

DUBLIN, April 29, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a...

April marks Stress Awareness Month as attention grows around the harm of social media and the underlying cause of related stress.